MDCX (Medicus Pharma Ltd. Common Stock) Stock Analysis - Community

Medicus Pharma Ltd. Common Stock (MDCX) is a publicly traded Healthcare sector company. As of May 21, 2026, MDCX trades at $0.29 with a market cap of $16.06M and a P/E ratio of -0.11. MDCX moved +5.00% today. Year to date, MDCX is -81.88%; over the trailing twelve months it is -96.19%. Its 52-week range spans $0.25 to $8.94. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces MDCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade MDCX?

Rallies community data for MDCX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

MDCX Key Metrics

Key financial metrics for MDCX
MetricValue
Price$0.29
Market Cap$16.06M
P/E Ratio-0.11
EPS$-2.69
Dividend Yield0.00%
52-Week High$8.94
52-Week Low$0.25
Volume0
Avg Volume0
Revenue (TTM)$-221.25K
Net Income$-39.38M
Gross Margin0.00%

Latest MDCX News

Recent MDCX Insider Trades

  • VELOCITY FUND PARTNERS, LP sold 75.00K (~$578.94K) on May 20, 2025.

MDCX Analyst Consensus

2 analysts cover MDCX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.

Common questions about MDCX

How does the Rallies community trade MDCX?
Rallies community data for MDCX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for MDCX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for MDCX when enough community data is available.
Is MDCX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MDCX. It does not provide personalized investment advice.
MDCX

MDCX